SEC Form 4/A · accession 0001209191-15-016753
Tobira Therapeutics, Inc. · TBRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Michael A Metzger
Officer — President & CEO · Director
Period of report
Dec 3, 2014
Accepted (ET)
Feb 20, 2015 · 4:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311596
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $0.84 | Dec 3, 2014 | A | 837,531 | A | — | Dec 2, 2024 | Common Stock | 837,531 | 837,531 | D |
Explanation of responses
- F1This amendment is being filed solely to correct the exercise price of the stock option, which due to an administrative error was reported as $0.85 on the original Form 4. The correct exercise price is $0.84.
- F2The option is vested and exercisable as to 209,383 shares. The remaining 628,148 shares underlying the option will vest in 36 equal monthly installments on the ninth day of each calendar month, commencing on November 9, 2014.